Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

Journal: Science

Published: 2020-08-07

DOI: 10.1126/science.abc6027

Affiliations: 22

Authors: 30

Go to article
Institutions Share
Cochin Hospital, France 0.21
Department of Internal Medicine, Cochin Hospital, France 0.17
Laboratory of Innate Immunity, France 0.13
Laboratory of Immunogenetics of Pediatric Autoimmune Diseases, Imagine Institute, France 0.09
Institut Cochin, France 0.07
Paris-Cardiovascular Research Center (PARCC), France 0.07
Plateforme Cytométrie Pitié-Salpêtrière (CyPS), France 0.07
Cytometry and Biomarkers (UTechS CB), Pasteur Institute, France 0.05
Laboratory of Insect-Virus Interactions, France 0.03
Georges Pompidou European Hospital (HEGP), France 0.03
University of Paris, France 0.02
Génomique Fonctionnelle des Tumeurs Solides, France 0.01
Cordelier Research Center (CRC), France 0.01
Hôpital Necker-Enfants Malades, France 0.01
Collège de France, France 0.01
Infection, Antimicrobials, Modelling, Evolution (IAME), France 0.01
Pasteur Institute, France 0.01

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER